Companies and Markets
Call us on +44 (0) 203 086 8600
Market Research A to Z | Company Profiles A to Z | RegisterRegister | Contact UsContact Us | Shopping Basket Shopping Basket
+44 (0) 203 086 8600 Call us on

Exonhit S.A. (ALEHT) - Financial and Strategic SWOT Analysis Review

Exonhit S.A. (Exonhit) is a medical diagnostic company. It focuses on developing and marketing genomic profiling technology, diagnostic solutions and drugs. The company develops targeted innovative therapeutic and diagnostic products in the areas oncology and Alzheimers disease. Exonhit invests strategically, both in internal research programs and strategic partnerships. It collaborates with academic and industrial partners by participating in a consortium of research and development funded by the European community. In the US Exonhit operates through its subsidiary, Exonhit Inc. Exonhit is headquartered in Paris, France.

Exonhit S.A. Key Recent Developments

Sep 11, 2012: Exonhit Reports Revenue Of €2.3m In H1 2012
Jun 05, 2012: Exonhit Receives €1.93m From OSEO For Personalized Medicine TEDAC Project In Cancer
Mar 22, 2012: Exonhit Reports Revenue Of €5m In 2011
Mar 05, 2012: Exonhit Receives €418,000 EU Grant Through Responsify Consortium
Nov 02, 2011: ExonHit Extends Strategic Collaboration With Allergan Sales

Change Currency

GBP
USD

Visitor Comments

All posts are pre-moderated and must obey the house rules.

Change Currency

GBP
USD

Use our research skills: Get free support

Free Research Support: Let us do the work for you and find information from public and private sources of information. Contact us now and we can save you time and money.......Free Research Support

eBrandPromote: Get your brands ranked highly online

eBrandPromote: Let us promote your brand online through article writing, press release distribution, social media and search engine marketing services. Click here to download our eBrandPromote brochure.

Accessibility
Close

Contrast settings

Text size settings